Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice

被引：0

作者：

B. Ferger

P. Teismann

C.D. Earl

K. Kuschinsky

W.H. Oertel

机构：

[1] Institut für Pharmakologie und Toxikologie,

[2] Fachbereich Pharmazie,undefined

[3] Philipps-Universität Marburg,undefined

[4] Ketzerbach 63,undefined

[5] D-35032 Marburg,undefined

[6] Medizinisches Zentrum für Nervenheilkunde,undefined

[7] Klinik für Neurologie,undefined

[8] Philipps-Universität Marburg,undefined

[9] Rudolf-Bultmann-Strasse 8,undefined

[10] D-35033 Marburg,undefined

来源：

Naunyn-Schmiedeberg's Archives of Pharmacology | 1999年 / 360卷

关键词：

Salicylic acid Hydroxyl radicals 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinson's disease Radical scavenger Neuroprotection;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The analgesic and anti-inflammatory drug sodium salicylate was studied for its potential protective effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. C 57BL/6 mice were treated with a single dose of sodium salicylate (50 mg/kg or 100 mg/kg i.p.) or saline immediately before injection of MPTP (30 mg/kg or 40 mg/kg s.c.) or saline. Analysis of striatal dopamine and metabolites as well as immunostaining for tyrosine hydroxylase of nigral sections was performed 7 days after MPTP treatment.

引用

页码：256 / 261

页数：5

共 50 条

[1] Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice
Ferger, B
Teismann, P
Earl, CD
Kuschinsky, K
Oertel, WH
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 360 (03) : 256 - 261
[2] Pramipexole protects against MPTP-induced nigral dopaminergic cell loss in primates
Jenner, P
Iravani, MM
Haddon, CO
Johnston, LC
Jackson, MJ
Smith, L
Rose, S
Schapira, A
NEUROLOGY, 2002, 58 (07) : A494 - A494
[3] PRETREATMENT WITH NIMODIPINE PREVENTS MPTP-INDUCED NEUROTOXICITY AT THE NIGRAL, BUT NOT AT THE STRIATAL LEVEL IN MICE
KUPSCH, A
GERLACH, M
PUPETER, SC
SAUTTER, J
DIRR, A
ARNOLD, G
OPITZ, W
PRZUNTEK, H
RIEDERER, P
OERTEL, WH
NEUROREPORT, 1995, 6 (04) : 621 - 625
[4] S-allyl cysteine protects against MPTP-induced striatal and nigral oxidative neurotoxicity in mice: Participation of Nrf2
Garcia, Esperanza
Santana-Martinez, Ricardo
Silva-Islas, Carlos A.
Colin-Gonzalez, Ana Laura
Galvan-Arzate, Sonia
Heras, Yessica
Maldonado, Perla D.
Sotelo, Julio
Santamaria, Abel
FREE RADICAL RESEARCH, 2014, 48 (02) : 159 - 167
[5] Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice
Parain, K
Marchand, V
Dumery, B
Hirsch, E
BRAIN RESEARCH, 2001, 890 (02) : 347 - 350
[6] Apomorphine protects against MPTP-induced neurotoxicity in mice
Grünblatt, E
Mandel, S
Berkuzki, T
Youdim, MBH
MOVEMENT DISORDERS, 1999, 14 (04) : 612 - 618
[7] Exercise protects against MPTP-induced neurotoxicity in mice
Gerecke, Kimberly M.
Jiao, Yun
Pani, Amar
Pagala, Vishwajeeth
Smeyne, Richard J.
BRAIN RESEARCH, 2010, 1341 : 72 - 83
[8] Recruitment of calbindin into nigral dopamine neurons protects against MPTP-Induced parkinsonism
Inoue, Ken-ichi
Miyachi, Shigehiro
Nishi, Katsunori
Okado, Haruo
Nagai, Yuji
Minamimoto, Takafumi
Nambu, Atsushi
Takada, Masahiko
MOVEMENT DISORDERS, 2019, 34 (02) : 200 - 209
[9] Melatonin, an antioxidant, protects against methamphetamine but not against MPTP-induced dopaminergic neurotoxicity
Ali, SF
Martin, JL
Black, MD
Itzhak, Y
JOURNAL OF NEUROCHEMISTRY, 1999, 73 : S190 - S190
[10] Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice
Aubin, N
Curet, O
Deffois, A
Carter, C
JOURNAL OF NEUROCHEMISTRY, 1998, 71 (04) : 1635 - 1642

← 1 2 3 4 5 →